請用此 Handle URI 來引用此文件: http://hdl.handle.net/11455/40219
標題: A Novel Cancer Therapy by Skin Delivery of Indoleamine 2,3-Dioxygenase siRNA
作者: Yen, M.C.
林季千
Lin, C.C.
Chen, Y.L.
Huang, S.S.
Yang, H.J.
Chang, C.P.
Lei, H.Y.
Lai, M.D.
關鍵字: human dendritic cells
dna vaccine
tryptophan degradation
antitumor
immunity
ido expression
tumor-immunity
t-cells
inhibition
immunotherapy
tolerance
期刊/報告no:: Clinical Cancer Research, Volume 15, Issue 2, Page(s) 641-649.
摘要: Purpose: Indoleamine 2,3-dioxygenase (IDO), an enzyme that degrades tryptophan, is a negative immune regulatory molecule of dendritic cells. IDO-expressing dendritic cells suppress T cell responses and may be immunosuppressive in vivo. We hypothesized that silencing the IDO expression in skin dendritic cells in vivo could elicit antitumor activity in tumor-draining lymph nodes. Experimental Design: The efficiency of IDO-specific small interfering RNA (si RNA) was evaluated in vitro and in vivo. The therapeutic effect was evaluated in MBT-2 murine bladder tumor model and CT-26 colon tumor models. Results: IDO expression was down-regulated in CD11c-positive lymphocytes after IDO siRNA treatment. In vivo skin administration of IDO siRNA inhibited tumor growth and prolonged survival in both tumor models. The number of infiltrated T cells and neutrophils increased at tumor sites, which are correlated with therapeutic efficacy. The T cells may be mainly responsible for the immunologic rejection because the effect was abolished by depletion of CD8-positive T cells. Adoptive transfer of CD11c-positive dendritic cells from vaccinated mice delayed tumor progression. The cancer therapeutic effect was reproducibly observed with another IDO siRNA targeting at different site, suggesting the effect was not due to off-target effect. In a neu-overexpressing MBT-2 tumor model, IDO siRNA enhanced the therapeutic efficacy of Her2/Neu DNA vaccine. Down-regulation of IDO2, an IDO homologue, with siRNA also generated antitumor immunity in vivo. Conclusions: Antitumor immunity can be effectively elicited by physical delivery of siRNAs targeting immunoregulatory genes in skin dendritic cells in vivo, as shown by IDO and IDO2 in this report
URI: http://hdl.handle.net/11455/40219
ISSN: 1078-0432
文章連結: http://dx.doi.org/10.1158/1078-0432.ccr-08-1988
顯示於類別:生物醫學研究所

文件中的檔案:
沒有與此文件相關的檔案。


在 DSpace 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。